Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the date of an upcoming Board Meeting where the company will consider and approve audited and unaudited financial results for a specific period. It also mentions the consideration of an interim dividend payment. The document is short (1416 characters) and serves as a notification of a future event rather than containing any financial data or results itself. This fits the description of a Regulatory Filing (RNS) as it is a general regulatory announcement about a board meeting and upcoming financial results, not the results or report themselves.
2022-01-10 English
Intimation of Issue of Duplicate Share Certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about notifying the exchanges of a corporate action related to share certificates, specifically the issuance of duplicates, and includes details such as folio numbers, shareholder names, and certificate numbers. This is not a financial report, earnings release, or management discussion. It is a corporate announcement related to share capital management but does not involve new share issues or capital changes like stock splits or new offerings. It is also not a director's dealing or share repurchase. The closest fitting category is Regulatory Filings (RNS), which serves as a general category for regulatory announcements and compliance documents that do not fit other specific categories.
2022-01-07 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management and shareholder records. The content is about notifying the exchanges of a corporate action related to share certificates, specifically the issuance of duplicates, and includes details such as folio numbers, shareholder names, and certificate numbers. This is not a financial report, earnings release, or management discussion. It is a regulatory announcement related to share capital administration but does not involve new share issuance or capital changes. The closest fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. The document length is short (1623 characters), and it is a notification letter rather than a report or presentation.
2022-01-07 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39, which pertains to share certificate matters. The content is about notifying the exchanges of a corporate action related to share certificates, not a financial report, management change, or earnings announcement. The document length is short (1604 characters) and is an official notification of a corporate action related to shares. This fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding share certificates and capital changes.
2022-01-07 English
News Verification
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing clarification on a news item about a product recall. It responds to specific queries regarding negotiations/events, undisclosed information, and material impact related to the recall. The content is a regulatory clarification rather than a financial report, earnings release, or management discussion. The document length is short (2279 characters) and it does not contain financial statements or detailed financial data. It is not an announcement of a report but a direct regulatory communication. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-12-29 English
Clarification
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing clarification on a news item about a product recall. It responds to specific queries regarding negotiations/events, undisclosed information, and material impact related to the recall. The content is a regulatory clarification rather than a financial report, earnings release, or management discussion. The document is short (2279 characters) and does not contain financial data or detailed report content. It is a regulatory announcement responding to an inquiry, fitting best under Regulatory Filings (RNS).
2021-12-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.